Table 1.
Correlation between the clinicopathological features and RhoGDI expression
| Characteristics | RhoGDI expression | ||
|---|---|---|---|
|
| |||
| Negative (%) | Positive (%) | P value | |
| Group | |||
| Non-tumor | 44 (41.5) | 62 (58.5) | 0.123 |
| Tumor | 40 (31.7) | 86 (68.3) | |
| Gender | |||
| Male | 36 (32.1) | 76 (67.9) | 0.787 |
| Female | 4 (28.6) | 10 (71.4) | |
| Age | |||
| <50 | 29 (41.4) | 41 (58.6) | 0.009* |
| ≥50 | 11 (19.6) | 45 (80.4) | |
| Tumor size (cm in diameter) | |||
| ≤5 | 14 (32.6) | 29 (67.4) | 0.888 |
| >5 | 26 (31.3) | 57 (68.7) | |
| Tumor differentiation | |||
| Low | 5 (29.4) | 12 (70.6) | 0.888 |
| Middle | 16 (34.0) | 31 (66.0) | |
| High | 19 (30.6) | 43 (69.4) | |
| Liver cirrhosis | |||
| No | 15 (26.8) | 41 (73.2) | 0.285 |
| Yes | 25 (35.7) | 45 (64.3) | |
| HBsAg status | |||
| Negative | 6 (37.5) | 10 (62.5) | 0.597 |
| Positive | 34 (30.9) | 76 (69.1) | |
| Serum AFP | |||
| Negative | 10 (29.4) | 24 (70.6) | 0.732 |
| Positive | 30 (32.6) | 62 (67.4) | |
| Postsurgical recurrence | |||
| Negative | 52 (66.7) | 26 (33.3) | 0.634 |
| Positive | 30 (62.5) | 18 (37.5) | |
| Postsurgical metastasis | |||
| No | 32 (31.1) | 71 (68.9) | 0.729 |
| Yes | 8 (34.8) | 15 (65.2) | |
*
Statistically significant (P<0.05).